Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Markers of early disease and prognosis in COPD.

International journal of chronic obstructive pulmonary disease - 1 Jan 2009

Dahl Morten, Nordestgaard Børge G

Abstract excerpt

COPD is a complex disease with multiple pathological components, which we unfortunately tend to ignore when spirometry is used as the only method to evaluate the disorder. Additional measures are needed to allow a more complete and clinically relevant assessment of COPD. The earliest potential risk factors of disease in COPD are variations in the genetic background. Genetic variations are present from conception...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to alpha 1-Antitrypsin Deficiency
Share to C-Reactive Protein
Share to Denmark

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Early Diagnosis

Share to Fibrinogen

Share to Hospitalization

Share to Mannose-Binding Lectin

Share to Pulmonary Disease, Chronic Obstructive

Source

Open in PubMed Open full text

Identifiers

PMID: 19436688
DOI: 10.2147/copd.s3106
PMCID: PMC2672792

Genes

CFTR
CRP

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Markers of early disease and prognosis in COPD.PMID 19436688Read ↗

Biomarkers in chronic obstructive pulmonary disease.Semantic proximity Read ↗

Pulmonary Physiology of Chronic Obstructive Pulmonary Disease, Cystic Fibrosis, and Alpha-1 Antitrypsin Deficiency.Semantic proximity Read ↗

Biomarkers for precision medicine in airways disease.Semantic proximity Read ↗

The potential value of biomarkers in diagnosis and staging of COPD and exacerbations.Semantic proximity Read ↗

Alpha-1 antitrypsin deficiency: whom to test, whom to treat?Semantic proximity Read ↗

Biomarkers in the assessment and management of airways diseases.Semantic proximity Read ↗

[Biomarkers in COPD--do we need them?].Semantic proximity Read ↗

Patient phenotyping and early disease detection in chronic obstructive pulmonary disease.Semantic proximity Read ↗

Genetic determinants of C-reactive protein in COPD.Semantic proximity Read ↗

Systemic biomarkers in the evaluation and management of COPD patients: are we getting closer to clinical application?Semantic proximity Read ↗

Which pulmonary function tests best differentiate between COPD phenotypes?Semantic proximity Read ↗

Genetic predisposition to accelerated decline of lung function in COPD.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.